The Association for Accessible Medicines has appointed former Biotechnology Innovation Organization representative Joanne Duncan as its new chief operating officer.  Meanwhile, Coherus has names the new chair of its scientific advisory board, while women’s health specialist Theramex has added to its board of directors. 

JB Chemicals posted yet another strong quarter of growth to cap off its 2021 financial year, with broad revenue increases and a focus on ‘cost excellence’ leading to increased profit margins.   

More C-Suite level pharma executives are lending their domain expertise to private equity firms, which then use their skills for commercial due diligence on targets or in an operating partner role in portfolio companies once a deal is sealed. PEs are also increasingly opting for control deals, at least in India, with an aim to run the acquired firm professionally thereon.

JB Chemicals posted strong revenue and profit growth in the first nine months of its 2021 financial year, six months after KKR bought a controlling stake in the company and a management shake-up.